RAD18 and lung cancer: Aberrantly expressed REV1 acts as a scaffolding protein to assist the interaction between the Rad18 E3 ubiquitin ligase and CTH, promoting CTH ubiquitination-mediated degradation and inducing remodeling of the amino acid metabolic microenvironment, leading to lung cancer radioresistance.